SEC 13F Intelligence

Managers / Q2 2023 · view latest →

Siguler Guff Advisers, LLC

CIK 0001328551 · 200 PARK AVENUE, 14TH FLOOR, NEW YORK, NY, 10166 · 212 332-5100

Reported Value
$226M
Q2 2023
Positions
7
Filings on Record
11
2019–present window
Filed
Jul 31, 2023
original filing

Summary

Siguler Guff Advisers, LLC reported $226M in U.S.-listed holdings across 7 positions for Q2 2023.

The portfolio is heavily concentrated: RPRX alone accounts for 46.2% of reported value.

Compared with Q1 2023, the fund opened 1 new position and exited 0.

Portfolio Metrics

Turnover
+0.6%
vs prior filed quarter
Largest Position
+46.2%
Royalty Pharma

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’23: $256MQ1 ’23Q2 ’23: $226MQ3 ’23: $196MQ3 ’23Q4 ’23: $250MQ1 ’24: $251MQ1 ’24Q2 ’24: $233MQ3 ’24: $269MQ3 ’24Q4 ’24: $201MQ1 ’25: $72MQ1 ’25Q2 ’25: $70MQ3 ’25: $56MQ3 ’25filingsflow.com

Portfolio Composition

By security type
Common Stock: 90.4%REIT: 6.6%Other: 3.0%
  • Common Stock · 90.4% · $204M
  • REIT · 6.6% · $15M
  • Other · 3.0% · $7M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TOSTTOAST INCNEW+60.4K60.4K+$1M$1M
RPRXROYALTY PHARMA PLCHELD+03.39M$18M$104M
FYBRFRONTIER COMMUNICATIONS PAREHELD+01.43M$6M$27M
SEMRUSH HLDGS INCHELD+507.27M$3M$70M
SVCSERVICE PPTYS TRHELD+01.71M$2M$15M
FATHOM DIGITAL MFG CORPHELD+016.63M$2M$7M
PNBKPATRIOT NATL BANCORP INCHELD+0299.7K$281,728$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2023

7 positions
#IssuerClass% PortfolioValueShares
1RPRXROYALTY PHARMA PLChistory →SHS CL A46.16%$104M3.39M
2SEMRUSH HLDGS INCCL A COM30.81%$70M7.27M
3FYBRFRONTIER COMMUNICATIONS PAREhistory →COM11.79%$27M1.43M
4SVCSERVICE PPTYS TRhistory →COM SH BEN INT6.57%$15M1.71M
5FATHOM DIGITAL MFG CORPCLA A COM3.02%$7M16.63M
6PNBKPATRIOT NATL BANCORP INChistory →COM NEW1.05%$2M299.7K
7TOSTTOAST INCCl A0.60%$1M60.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$56M2Oct 15, 202513F-HRchanges · EDGAR ↗
Q2 2025$70M2Jul 29, 202513F-HRchanges · EDGAR ↗
Q1 2025$72M2Apr 29, 202513F-HRchanges · EDGAR ↗
Q4 2024$201M4Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$269M5Oct 28, 202413F-HRchanges · EDGAR ↗
Q2 2024$233M5Jul 25, 202413F-HRchanges · EDGAR ↗
Q1 2024$251M6Apr 26, 202413F-HRchanges · EDGAR ↗
Q4 2023$250M6Jan 29, 202413F-HRchanges · EDGAR ↗
Q3 2023$196M6Oct 19, 202313F-HRchanges · EDGAR ↗
Q2 2023$226M7Jul 31, 202313F-HRchanges · EDGAR ↗
Q1 2023$256M6May 5, 202313F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.